Herbal granule shows promise in easing kidney harm from cancer drugs

NCT ID NCT05673824

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether Huaier Granule, a traditional Chinese medicine, can reduce protein in the urine—a sign of kidney damage—caused by anti-angiogenesis targeted therapy in 76 adults with advanced liver or bile duct cancer. Participants took the granule for 8 weeks, and researchers measured changes in urine protein levels. The goal was to see if the treatment could ease this side effect without curing the cancer itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED HEPATOBILIARY MALIGNANCIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fudan University Shanghai Cancer Center

    Shanghai, Shanghai Municipality, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.